HUMAX
Live / Registered — Registered — Section 71 accepted (as of 24 Feb 2026)
What this means for you
Registered since 22 Nov 2005. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79006609
- Registration number
- 3018118
- Mark type
- Stylized text
- Filed
- 30 Sept 2004
- Published for opposition
- 30 Aug 2005
- Registered
- 22 Nov 2005
- Attorney of record
- Max Vern
Goods and services
- Class 001 — Chemicals: Chemicals used in industry and science, namely, monoclonal antibodies for in vivo or in vitro scientific research and development regarding cancer [ AIDS (acquired immune deficiency syndrome), and other infectious diseases, autoimmune diseases, and cardiovascular diseases ]
- Class 005 — Pharmaceuticals: Pharmaceutical preparations based on human monoclonal antibodies for the treatment of cancer [ AIDS (acquired immune deficiency syndrome), and other infectious diseases, autoimmune diseases, and cardiovascular diseases ]
Owner
- Genmab A/S, Valby, DK
- Genmab A/S, DK
- Genmab A/S, DK
Prosecution history
- 24 Feb 2026 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 24 Feb 2026 — REGISTERED-SEC.71 ACCEPTED
- 23 Feb 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Oct 2025 — TEAS SECTION 71 RECEIVED
- 21 Mar 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 22 Nov 2024 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 05 Jun 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 05 Jun 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 Jun 2024 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 05 Jun 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Jun 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 Jun 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 05 Jun 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 15 Sept 2023 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 15 Apr 2021 — INTERNATIONAL REGISTRATION RENEWED